scholarly journals Rhabdomyolysis and Acute Kidney Injury Associated with Hypothyroidism and Statin Therapy

2013 ◽  
Vol 28 (4) ◽  
pp. 331 ◽  
Author(s):  
Pyoung Ahn ◽  
Hyun-Jun Min ◽  
Sang-Hyun Park ◽  
Byoung-Mu Lee ◽  
Myung-Jin Choi ◽  
...  
2020 ◽  
Author(s):  
Mikayla Welch ◽  
Naser Gharaibeh

Abstract BackgroundHashimoto’s thyroiditis is typically diagnosed incidentally from elevated TSH or after evaluation of suggestive symptoms, including weight gain and fatigue. Rarely, patients present with an initial hyperthyroid state, Hashitoxicosis, that lasts weeks to months. Through a review of the current literature, it became apparent that this case is unique in several ways: the patient’s age, lack of comorbid conditions, the unique presentation of her thyroid disease, as well as the development of acute kidney injury while hospitalized.Case PresentationHere we present the case of a 26-year-old female who was referred to the Endocrinology office in July 2019 with symptoms of hyperthyroidism. She has a positive family history of Graves’ disease (GD) in her mother and thyroid malignancy in her maternal aunt. On her initial visit, TSH was suppressed, free thyroid hormones were increased, and both TPO and TSI antibodies were elevated. It was determined that this was likely a presentation of GD, and the patient was started on methimazole. She was instructed to follow-up every four weeks for monitoring of symptoms and labs. Three months following the initial visit, the patient failed to follow-up in office. During this time, she was seen by her primary care physician, diagnosed with hyperlipidemia, and started on statin therapy. One month later, on a subsequent follow-up with endocrinology, the patient complained of new onset back pain, muscle cramps, weight gain, and cold intolerance. She was sent to the emergency department for work-up. Evaluation revealed rhabdomyolysis in the setting of severe hypothyroidism, complicated by acute kidney injury. Her final diagnosis was found to be Hashitoxicosis with subsequent hypothyroidism.ConclusionsHyper- and hypothyroidism are two extremes on the spectrum of autoimmune thyroid disease, and the presentation can vary from patient-to-patient. Rarely, severe hypothyroidism can present with rhabdomyolysis with increased risk in patients on statin therapy. Thus, it is important to ensure patients are clinically and biochemically euthyroid prior to initiation of statin therapy. This case emphasizes the need for communication among physicians and the importance of patient adherence to treatment plans.


2010 ◽  
Vol 24 (6) ◽  
pp. 913-920 ◽  
Author(s):  
Frederic T. Billings ◽  
Mias Pretorius ◽  
Edward D. Siew ◽  
Chang Yu ◽  
Nancy J. Brown

2010 ◽  
Vol 111 (2) ◽  
pp. 324-330 ◽  
Author(s):  
Maged Argalious ◽  
Meng Xu ◽  
Zhiyuan Sun ◽  
Nicholas Smedira ◽  
Colleen G. Koch

Critical Care ◽  
2015 ◽  
Vol 19 (1) ◽  
Author(s):  
Patrick M. Honore ◽  
Rita Jacobs ◽  
Inne Hendrickx ◽  
Elisabeth De Waele ◽  
Viola Van Gorp ◽  
...  

2021 ◽  
Author(s):  
Maoning Lin ◽  
Tian Xu ◽  
Wenjuan Zhang ◽  
Duanbin Li ◽  
Ya Li ◽  
...  

Abstract Background: Post-Contrast acute kidney injury (PC-AKI) is a severe complication of coronary angiography (CAG) and percutaneous coronary intervention (PCI). At present, the mechanism and effect of statins on PC-AKI and its mechanism are still unclear. Methods: It was a multicenter retrospective obeservational study. We reviewed 4386 patients who underwent CAG or PCI, with serum creatinine recorded pre- or post-procedure within 72hrs after PCI, from December, 2006 to December, 2019 admitted to Sir Run Run Shaw Hospital and its medical consortium hospitals. Multivariate logical regression was used to explore whether preoperative use of statins was a protective factor for PC-AKI, and then path analysis model was used to explore the specific mechanism of statins. Results: In total, 4386 patients were enrolled in the study, the mean age was 67 yrs old, 17.9% with PC-AKI, 83.3% with pre-operative statin therapy. The incidence of PC-AKI was significantly lower in statin therapy group than non-statins therapy group. Multivariate regression indicated that pre-operative statin therapy was significantly negatively associated with percentage of elevated creatinine (β: -0.118, p<0.001) and PC-AKI (OR: 0.575, p<0.001). In pre-operative statin therapy group, no statistically significant deference was detected between atorvastatin and rosuvastatin group (OR: 1.052, p=0.558). Pathway model analysis indicated the direct protective effectiveness of pre-operative statin therapy on PC-AKI (p<0.001), but neither with its lipid-lowering effect (p=0.277) nor anti-inflammatory effect (p=0.596). Furthermore, It was found that “LDL-C→CRP” mediated the relationship between pre-operative statin therapy and PC-AKI (p=0.007); however, only explained less than 1% of the pre-operative statin therapy’s protective effects on PC-AKI. Conclusion: Pre-operative statin therapy is an independent protective factor of PC-AKI, which is not affected by the type of statins and not achieved by lipid-lowering effect or anti-inflammatory effect. Keywords : post-contrast acute kidney injury, statins, path analysis, mediation analysis.


2018 ◽  
Vol 8 (1) ◽  
pp. 25 ◽  
Author(s):  
Tak Oh ◽  
In-Ae Song ◽  
Young-Jae Cho ◽  
Cheong Lim ◽  
Young-Tae Jeon ◽  
...  

This study aimed to investigate the association between preadmission statin use and acute kidney injury (AKI) incidence among critically ill patients who needed admission to the intensive care unit (ICU) for medical care. Medical records of patients admitted to the ICU were reviewed. Patients who continuously took statin for >1 month prior to ICU admission were defined as statin users. We investigated whether preadmission statin use was associated with AKI incidence within 72 h after ICU admission and whether the association differs according to preadmission estimated glomerular filtration rate (eGFR; in mL min−1 1.73 m−2). Among 21,236 patients examined, 5756 (27.1%) were preadmission statin users and 15,480 (72.9%) were non-statin users. Total AKI incidence within 72 h after ICU admission was 31% lower in preadmission statin users than in non-statin users [odds ratio (OR), 0.69; 95% confidence interval (CI), 0.61–0.79; p < 0.001]. This association was insignificant among individuals with eGFR <30 mL min−1 1.73 m−2 (p > 0.05). Our results suggested that preadmission statin therapy is associated with a lower incidence of AKI among critically ill patients; however, this effect might not be applicable for patients with eGFR <30 mL min−1 1.73 m−2.


Nephrology ◽  
2014 ◽  
Vol 19 (12) ◽  
pp. 750-763 ◽  
Author(s):  
Szu-Yu Pan ◽  
Vin-Cent Wu ◽  
Tao-Min Huang ◽  
Hou-Chang Chou ◽  
Wen-Je Ko ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document